IP Library Granted Patent US 9,498,459
Granted Patent B2
US 9,498,459 · App. 14/204,816 · Granted Nov 22, 2016

Sodium containing sol-gel derived bioactive glasses and uses thereof including hemostasis

Inventors: Gregory J. Pomrink (Newberry, FL); Jipin Zhong (Gainesville, FL); Zehra Tosun (Gainesville, FL); Roy Layne Howell (Gainesville, FL); Cecilia Cao (Gainesville, FL)
Assignee: NOVABONE PRODUCTS, LLC
A61K31/216A61K31/415A61K31/4439A61K31/454A61K31/58A61K31/65A61K45/06A61L27/10A61L27/52A61L2400/04A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,498,459
App. No.
14/204,816
Granted
Nov 22, 2016
Kind
B2
Abstract

A sol-gel bioactive glass precursor, method for making sol-gel glasses, resultant sol-gel bioactive glasses, and methods of use thereof which include introducing Na 2 O into the glass network during the sol-gel process through the use of Na-ethoxide, NaCl, or sodium silicate rather than sodium nitrate. Medical and industrial uses of such glasses.

Claims (38)

1. A sol-gel bioactive glass comprising Si, Ca, P, and Na, wherein the sol-gel bioactive glass is derived from a mixture including a sodium source selected from the group consisting of NaCl and C 2 H 5 ONa, the sol-gel bioactive glass having a porous structure and a significantly higher specific surface area as compared to a melt-derived bioactive glass of the same composition, wherein the sol-gel bioactive glass is strontium free, wherein the significantly higher specific surface area is at least 30 times higher than the melt-derived bioactive glass specific surface area.

2. The sol-gel bioactive glass of claim 1 , wherein the Na source is NaCl.

3. The sol-gel bioactive glass of claim 1 , wherein the Na source is C 2 H 5 ONa.

4. The sol-gel bioactive glass of claim 1 , wherein the bioactive sol-gel glass is in a granular form, particulate form, matt form, fiber form, hemostatic sponge form, foam form, paste or putty form, or sphere or bead form, or a combination thereof.

5. A method of making mthe sol-gel bioactive glass of claim 1 including Si, Ca, P, and Na comprising:

mixing a sol-gel bioactive glass precursor including a source of Si, Ca, P, and Na, wherein the sodium source is selected from the group consisting of NaCl and C 2 H 5 ONa;

aging the mixture, and

drying the mixture to form the sol-gel bioactive glass.

6. The method of claim 5 , wherein said aging is conducted at a temperature of 50-80° C. for 40-70 hours.

7. The method of claim 5 , further comprising sintering at 500-900° C. for 15 to 50 hours.

8. A method for achieving hemostasis in a patient in need of treatment thereof comprising contacting the patient with the sol-gel bioactive glass of claim 1 .

9. A method of inducing rapid coagulation in a bleeding patient comprising contacting the patient with the sol-gel bioactive glass of claim 1 .

10. The sol-gel bioactive glass of claim 1 , wherein Si, Ca, P, and Na are present in their oxide form of SiO 2 , CaO, P 2 O 5 , and Na 2 O.

11. The sol-gel bioactive glass of claim 10 , further comprising one or more of K, Mg, Zn, B, F, or Ag.

12. A method of making the sol-gel bioactive glass of claim 1 including Si, Ca, P, and Na comprising:

mixing a sol-gel bioactive glass precursor including a source of Si, Ca, P, and Na, wherein the sodium source is selected from the group consisting of NaCl and C 2 H 5 ONa, and

drying the mixture at a temperature of 100° C. or lower.

13. The method of claim 12 , further comprising adding a biologically active molecule.

14. A method of treating wounds in a patient comprising contacting the patient with the sol-gel bioactive glass of claim 1 .

15. A method of repairing bone in a patient comprising contacting the bone in need of treatment with the sol-gel bioactive glass of claim 1 .

16. A sol-gel bioactive glass comprising Si, an alkaline earth metal, P, and alkali metal, wherein the sol-gel bioactive glass is derived from a mixture including a sodium source other than sodium nitrate, the sodium source selected from organosodium containing compound or an inorganic sodium salt, the sol-gel bioactive glass having a porous structure and a significantly higher specific surface area as compared to a melt-derived bioactive glass of the same composition, wherein the sol-gel bioactive glass is strontium free, wherein the significantly higher specific surface area is at least 30 times higher than the melt-derived bioactive glass specific surface area.

17. A method for achieving hemostasis in a patient in need of treatment thereof comprising contacting the patient with the sol-gel bioactive glass of claim 16 comprising Si, Ca, P, and Na, wherein the sol-gel bioactive glass is derived from a mixture including a sodium source, wherein the sodium source is sodium silicate.

18. A method of making the sol-gel bioactive glass of claim 16 including Si, Ca, P, and Na comprising:

mixing a sol-gel bioactive glass precursor including a source of Si, Ca, P, and Na,

wherein the sodium source is sodium silicate;

aging the mixture, and

drying the mixture to form the sol-gel bioactive glass.

19. The sol-gel bioactive glass of claim 1 , wherein the mixture further includes a sol-gel bioactive glass precursor including a source of Si, Ca, P, and Na.

20. The sol-gel bioglass of claim 19 , wherein the Si source is tetraethoxysilane.

21. The sol-gel bioglass of claim 19 , wherein the Ca source is calcium nitrate tetra-hydrate.

22. The sol-gel bioglass of claim 19 , wherein the Ca source is calcium methoxide.

23. The sol-gel bioglass of claim 19 , wherein the P source is triethylphosphate or sodium hexametaphosphate.

24. The sol-gel bioglass of claim 19 , wherein the Na source is NaCl.

25. The sol-gel bioglass of claim 19 , wherein the source of Na is C 2 H 5 ONa and the sol-gel bioactive glass precursor is present in an amount to provide for 20-30% by weight of Na 2 O in a sol-gel bioactive glass.

26. The sol-gel bioglass of claim 19 , wherein the source of Na is NaCl and the sol-gel bioactive glass precursor is present in an amount to provide for 20-30% by weight of Na 2 O in a sol-gel bioactive glass.

27. The sol-gel bioglass of claim 19 , wherein the Na source is C 2 H 5 ONa.

28. The sol-gel bioglass of claim 19 , wherein the source of phosphorus is triethylphosphate and the sol-gel bioactive glass precursor is present in an amount to provide for 20-30% by weight of P 2 O 5 in a sol-gel bioactive glass.

29. The sol-gel bioglass of claim 1 , wherein the mixture further comprises a sol-gel bioactive glass precursor including a source of Si, Ca, and Na, wherein the sodium source is selected from the group consisting of NaCl and C 2 H 5 ONa.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: POMRINK, GREGORY J.; ZHONG, JIPIN; TOSUN, ZEHRA; HOWELL, ROY LAYNE; CAO, CECILIA A.
To: NOVABONE PRODUCTS, LLC
Reel/Frame 033214/0702 →
Continuity (3)
Provisional Application 61782849 · Mar 14, 2013
Provisional Application 61786991 · Mar 15, 2013
Related Publication 20140271912A1 · Sep 18, 2014